Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-16
2000-10-17
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514397, 540603, 546210, 5483147, A61K 31445, C07D40106
Patent
active
061332917
ABSTRACT:
The present invention discloses novel N(imidazolylalkyl)-substituted cyclic amine compounds which have excellent histamine-H.sub.3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such cyclic amines as well as methods of using them to treat allergy, inflammatory and CNS-related diseases.
REFERENCES:
patent: 4006137 (1977-02-01), Haugwitz et al.
patent: 4238493 (1980-12-01), Roantree et al.
patent: 5463074 (1995-10-01), Shih et al.
patent: 5807872 (1998-09-01), Shih et al.
Lee "Preparation of acylpyrrolomethylimidazoles and analogs as farnesyl transferase inhibitors" CA 131:31940, 1999.
Robin et al. "Design or potent nonthiurea H3 receptor histamine antagonists" J. Med. chem. v.38, pp. 3342-3350, 1995.
darling et al. "Synthesis of histamine analogs" CA 84:90076, 1976.
Howson, Bioorg. & Med. Chem. Letters, 2(1), 77-78 (1992).
Van der Groot, Eur. J. Med. Chem., 27, 511-517 (1992).
Clapham, J. Psychopharmacol., (Abstracts book), A17 (1993).
Clapham, British J. Pharm. Suppl., 110, Abstract 65P (1993).
Yokoyama, European J. Pharmacology, 234, 129-133 (1993).
Schlicker, British J. Pharmacology, 112, 1043-1048 (1994).
Leurs, Prog. Drug. Res., 39, 127-165 (1992).
Lipp, "The Histamine Receptor", ed. Schwartz and Haas, Wiley-Liss Publications, New York, New York, 57-72 (1992).
Bagley, J. Med. Chem., 34, 827-841 (1991).
Hey, European J. Pharmacology, 294, 329 (1995).
Afonso Adriano
Rosenblum Stuart B.
Wolin Ronald
Chang Ceila
Kalyanaraman Palaiyur S.
Schering Corporation
LandOfFree
N-(imidazolylalkyl)substituted cyclic amines as histamine-H.sub. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(imidazolylalkyl)substituted cyclic amines as histamine-H.sub., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(imidazolylalkyl)substituted cyclic amines as histamine-H.sub. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-469360